Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Tiantai Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturer based in Tiantai County, Zhejiang Province, China. Founded in 1998, the company operates as a key subsidiary of the publicly traded Zhejiang Xianju Pharmaceutical Co., Ltd. The firm specializes in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of anti-infectives and respiratory health. Its core product line includes widely used macrolide antibiotics such as Clarithromycin and Roxithromycin, as well as respiratory treatments like Ambroxol. Zhejiang Tiantai Pharmaceutical maintains state-of-the-art manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. The company serves a global customer base, exporting its products to numerous countries while maintaining a strong foothold in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tiantai.